You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
Trading
Institutions
Fees
Promotions
FAQ
Education
Download
About us
Hong Kong
uSMART
EN
Login/Register
Market News

Market News

HomeMarket NewsDetails

康希諾大幅拉昇，公告澄清新冠疫苗產能情況

uSMART盈立智投 11-25 10:21

港股早盤，康希諾生物由盤初下跌5%逆勢回漲，漲幅一度高達10%。

康希諾生物昨日公告澄清：本公司研發生產的吸入用重組新型冠狀病毒疫苗（5型腺病毒載體）作爲加強針被納入緊急使用後，本公司高度重視生產能力及運輸能力的相關工作，目前達到每天產能150萬人份，可實現運力達每天100萬人份，非"每天會有至少100萬人份運往全國"。

康希诺生物(06185.HK)
三叶草生物-B(02197.HK)
歌礼制药-B(01672.HK)
开拓药业-B(09939.HK)
Relevant Stocks
康希诺生物(06185.HK)
三叶草生物-B(02197.HK)
歌礼制药-B(01672.HK)
开拓药业-B(09939.HK)
Business Collaboration
Account Opening

Services

FeesFAQExclusive Trading Tools

About Us

OverviewContact UsMedia Center

Agreement Statement

DisclaimerPrivacy Statement
Contact Us
Customer Service Hotline︰+852 3018 4526
Email︰cs@usmarthk.com
Address︰26/F, 2606, 308 Des Voeux Road Central, Sheung Wan, Hong Kong
WhatsApp︰+852 5989 2641
Join the Community：
uSMART-Facebook-Page
uSmart Securities Limited
is a licensed corporation approved by the Hong Kong SFC (CE number: BJA907), provides securities trading services and is subject to its supervision.

Copyright © 2022 uSMART . All Rights Reserved.